SCHEMBL7397909

SCHEMBL7397909

Cc1cc(COc2ccc(C(=O)NC3(C(C)C(=O)NO)CCCCO3)cc2)c2ccccc2n1

nearest known ligand 0.64

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 12/20 0.64
ADAMTS4 O75173 2/20 0.62
MMP3 P08254 2/20 0.62
MMP7 P09237 2/20 0.62
ADAMTS1 Q9UHI8 2/20 0.62
ADAMTS5 Q9UNA0 2/20 0.62
MMP2 P08253 5/20 0.60
MMP9 P14780 3/20 0.60
MMP8 P22894 1/20 0.58
ADAM10 O14672 1/20 0.57
MMP1 P03956 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6597542 0.85 ADAM17 (0.71) ADAM17ADAMTS4MMP3MMP7ADAMTS1
SCHEMBL6598089 0.84 ADAM17 (0.63) ADAM17ADAMTS4MMP3MMP7ADAMTS1
SCHEMBL6597835 0.83 ADAM17 (0.67) ADAM17ADAMTS4MMP3MMP7ADAMTS1
SCHEMBL6596966 0.82 ADAM17 (0.71) ADAM17ADAMTS4MMP3MMP7ADAMTS1
Trifluoroacetic Acid SCHEMBL6597061 0.81 ADAM17 (0.66) ADAM17ADAMTS4MMP3MMP7ADAMTS1
SCHEMBL7552013 0.81 ADAM17 (0.78) ADAM17ADAMTS4MMP3MMP7ADAMTS1
SCHEMBL6596235 0.80 ADAM17 (0.64) ADAM17MMP2MMP9ADAM10MMP1
Trifluoroacetic Acid SCHEMBL6597906 0.80 ADAM17 (0.58) ADAM17ADAMTS4MMP3MMP7ADAMTS1
Trifluoroacetic Acid SCHEMBL6594971 0.80 ADAM17 (0.62) ADAM17ADAMTS4MMP3MMP7ADAMTS1
SCHEMBL6595027 0.79 ADAM17 (0.98) ADAM17ADAMTS4MMP3MMP7ADAMTS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263756-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP claimed
WO-2001070734-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO claimed